Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Henrik Hauswald"'
Autor:
Henrik Hauswald MD, Michael Schempp MS, Pauline Liebig MS, Sebastian Hoefel MS, Jürgen Debus MD, PhD, Peter E. Huber MD, PhD, Felix Zwicker MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Background: This retrospective study aimed to investigate the outcomes and adverse events (AEs) associated with adjuvant radiotherapy with helical tomotherapy (hT) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Methods: Tw
Externí odkaz:
https://doaj.org/article/a9296922b00448408e32b29c38e2009f
Autor:
Fabian Eberle, Rita Engenhart-Cabillic, Markus M. Schymalla, Christoph Dumke, Ulrike Schötz, Florentine S.B. Subtil, Kilian-Simon Baumann, Boris A. Stuck, Christine Langer, Alexandra D. Jensen, Henrik Hauswald, Stefan Lautenschläger
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundSurgery and radiotherapy are current therapeutic options for malignant tumors involving the nasal vestibule. Depending on the location, organ-preserving resection is not always possible, even for small tumors. Definitive radiotherapy is an
Externí odkaz:
https://doaj.org/article/e217217ae54b44f2ba0f900b3c242fb9
Autor:
Sati Akbaba, Robert Foerster, Nils Henrik Nicolay, Nathalie Arians, Tilman Bostel, Juergen Debus, Henrik Hauswald
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background The purpose of this retrospective analysis is to analyze clinical outcome, visual acuity and enucleation rates after linear accelerator-based stereotactic fractionated photon radiotherapy for primary uveal melanoma. Methods Twenty
Externí odkaz:
https://doaj.org/article/a8354effc0e740f6ae4e786025b54833
Autor:
Laila König, Henrik Hauswald, Christa Flechtenmacher, Martina Heller, Jürgen Debus, Uwe Haberkorn, Clemens Kratochwil, Frederik Giesel
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 7, Iss , Pp 79-82 (2017)
This case report shows the high PSMA-uptake in a patient with an adenoid cystic carcinoma of the maxillary sinus. Due to the intense ligand-uptake additional information for target volume delineation was obtained and the Treatment plan for bimodal ra
Externí odkaz:
https://doaj.org/article/b834a1ce241a4e0baa39d522a14435b8
Autor:
Rosario Astaburuaga, Hubert S. Gabryś, Beatriz Sánchez-Nieto, Ralf O. Floca, Sebastian Klüter, Kai Schubert, Henrik Hauswald, Mark Bangert
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Purpose: Due to the sharp gradients of intensity-modulated radiotherapy (IMRT) dose distributions, treatment uncertainties may induce substantial deviations from the planned dose during irradiation. Here, we investigate if the planned mean dose to pa
Externí odkaz:
https://doaj.org/article/fde485dc728d4e00a64374188454270a
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
PurposeThe purpose of this study is to investigate whether machine learning with dosiomic, radiomic, and demographic features allows for xerostomia risk assessment more precise than normal tissue complication probability (NTCP) models based on the me
Externí odkaz:
https://doaj.org/article/1aa401e25b25444b8f8821093b4b1583
Autor:
FELIX ZWICKER, RUDOLF KLEPPER, HENRIK HAUSWALD, SEBASTIAN HOEFEL, LUIS RAETHER, PETER E. HUBER, JUERGEN DEBUS, MICHAEL SCHEMPP
Publikováno v:
Anticancer Research. 43:2041-2053
Autor:
F. Eberle, A. Jensen, U. Keber, Rita Engenhart-Cabillic, F. S. Lautenschlaeger, Henrik Hauswald, R. Dumke, M. Schymalla, M. Stein, Barbara Carl
Publikováno v:
Strahlentherapie und Onkologie. 198:427-435
Purpose Purpose of this study was to investigate overall survival in recurrent glioblastoma treated with either carbon ion reirradiation or photon reirradiation. Materials and methods In this retrospective study we evaluated 78 consecutive patients w
Autor:
Henrik Hauswald, Kolja Freier, Alexandra D Jensen, Sati Akbaba, Thomas Held, Marc W. Münter, Vivek Verma, Stefan Rieken, Anna Nikoghosyan, Sebastian Adeberg, Juergen Debus, Klaus Herfarth, Denise Bernhardt, Peter Plinkert, Kristin Lang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 106:167-173
Purpose The adenoid cystic carcinoma (ACC), Erbitux, and Particle Therapy (ACCEPT) phase 1/2 trial (NCT01192087) evaluated a combined-modality approach (concurrent cetuximab and intensity modulated radiation therapy with carbon ion boost) for newly d
Autor:
Jürgen Debus, Marco Stein, Rita Engenhart-Cabillic, Fabian Eberle, Stefan Friedrich Lautenschläger, Henrik Hauswald, Alexandra D Jensen, Barbara Carl
Publikováno v:
Cancer Management and Research. 12:633-639
Background Patients with recurrent glioma after prior radiotherapy have a poor prognosis. Carbon ion beam radiotherapy offers highly conformal dose distributions and more complex biological radiation effects eventually resulting in optimized normal t